LEVIN ARTHUR A — SEC Form 4 filings
SEC reporting owner CIK 1181556. 29 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2024-01-23 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 17 filings — 304,558 shares, $11,923,738 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 47.
- Largest priced transaction: sale of 107,500 shares @ $47.62 ($5,118,881) in Avidity Biosciences, Inc., filed 2025-08-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) | Director | 20 | — | 18 legs · 303,953 sh · $11,901,474 | 35 |
| Stoke Therapeutics, Inc. (STOK) | Director | 9 | — | 1 leg · 605 sh · $22,264 | 12 |
Form 4 filings — LEVIN ARTHUR A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 605 @ $36.80 | EDGAR |
| 2026-02-27 | 4 | Avidity Biosciences, Inc. (RNAM) | Disposition to issuer (D): 16,562 · Disposition to issuer (D): 131,372 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 144,000 (derivative) · Disposition to issuer (D): 115,500 (derivative) · +1 more | EDGAR |
| 2026-01-23 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 1,758 @ $72.45 | EDGAR |
| 2026-01-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 1,211 @ $0 · Option exercise (M): 1,211 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Avidity Biosciences, Inc. (RNA) | Gift (G): 1,330 @ $0 | EDGAR |
| 2025-10-01 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 1,211 @ $0 · Option exercise (M): 1,211 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 107,500 @ $22.34 · Sale (S): 107,500 @ $47.62 · Option exercise (M): 107,500 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 1,210 @ $0 · Option exercise (M): 1,210 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 6,692 @ $0 · Grant/award (A): 10,034 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 29,747 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 1,210 @ $0 · Option exercise (M): 1,210 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 4,842 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 1,872 @ $28.60 | EDGAR |
| 2024-11-20 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 3,323 @ $1.24 · Sale (S): 3,323 @ $42.12 · Option exercise (M): 3,323 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 5,000 @ $1.24 · Sale (S): 5,000 @ $46.63 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 5,000 @ $1.24 · Sale (S): 5,000 @ $45.73 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | Avidity Biosciences, Inc. (RNA) | Gift (G): 22,500 @ $0 · Gift (G): 22,500 @ $0 | EDGAR |
| 2024-08-21 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 5,000 @ $1.24 · Sale (S): 5,000 @ $45.19 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-23 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 5,000 @ $1.24 · Sale (S): 5,000 @ $45.01 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 5,000 @ $1.24 · Sale (S): 5,000 @ $37.59 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 40,000 @ $35.07 · Sale (S): 60,000 @ $40.08 · Grant/award (A): 13,489 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 7,639 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 5,000 @ $1.24 · Sale (S): 5,000 @ $29.90 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-04-22 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 5,000 @ $1.24 · Sale (S): 5,000 @ $22.82 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 20,000 @ $27.11 | EDGAR |
| 2024-03-21 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 5,000 @ $1.24 · Sale (S): 5,000 @ $23.97 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 25,000 @ $1.24 · Sale (S): 25,000 @ $22.04 · Sale (S): 2,641 @ $22 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 1,859 @ $10.13 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1181556 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →